Share-based Payment Arrangement, Expense of IONIS PHARMACEUTICALS INC from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IONIS PHARMACEUTICALS INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • IONIS PHARMACEUTICALS INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $31,146,000, a 2.6% decline year-over-year.
  • IONIS PHARMACEUTICALS INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $126,702,000, a 5.2% increase year-over-year.
  • IONIS PHARMACEUTICALS INC annual Share-based Payment Arrangement, Expense for 2024 was $130,200,000, a 23% increase from 2023.
  • IONIS PHARMACEUTICALS INC annual Share-based Payment Arrangement, Expense for 2023 was $105,809,000, a 5.5% increase from 2022.
  • IONIS PHARMACEUTICALS INC annual Share-based Payment Arrangement, Expense for 2022 was $100,264,000, a 17% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

IONIS PHARMACEUTICALS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $126,702,000 $31,146,000 -$838,000 -2.6% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $127,540,000 $29,690,000 -$1,038,000 -3.4% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $128,578,000 $29,718,000 -$1,622,000 -5.2% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $130,200,000 $36,148,000 +$9,812,000 +37% 01 Oct 2024 31 Dec 2024 10-K 19 Feb 2025 2024 FY
Q3 2024 $120,388,000 $31,984,000 +$6,020,000 +23% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025 2025 Q3
Q2 2024 $114,368,000 $30,728,000 +$4,167,000 +16% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025 2025 Q2
Q1 2024 $110,201,000 $31,340,000 +$4,392,000 +16% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025 2025 Q1
Q4 2023 $105,809,000 $26,336,000 +$647,000 +2.5% 01 Oct 2023 31 Dec 2023 10-K 19 Feb 2025 2024 FY
Q3 2023 $105,162,000 $25,964,000 +$2,127,000 +8.9% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $103,035,000 $26,561,000 +$2,059,000 +8.4% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 $100,976,000 $26,948,000 +$712,000 +2.7% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $100,264,000 $25,689,000 +$3,431,000 +15% 01 Oct 2022 31 Dec 2022 10-K 19 Feb 2025 2024 FY
Q3 2022 $96,833,000 $23,837,000 -$6,700,000 -22% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $103,533,000 $24,502,000 -$5,520,000 -18% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $109,053,000 $26,236,000 -$11,625,000 -31% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q4 2021 $120,678,000 $22,258,000 -$72,782,000 -77% 01 Oct 2021 31 Dec 2021 10-K 21 Feb 2024 2023 FY
Q3 2021 $193,460,000 $30,537,000 -$15,308,000 -33% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $208,768,000 $30,022,000 -$18,420,000 -38% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $227,188,000 $37,861,000 -$2,929,000 -7.2% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $230,117,000 $95,040,000 +$60,030,000 +171% 01 Oct 2020 31 Dec 2020 10-K 22 Feb 2023 2022 FY
Q3 2020 $170,087,000 $45,845,000 +$21,719,000 +90% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $148,368,000 $48,442,000 +$6,509,000 +16% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021 2021 Q2
Q1 2020 $141,859,000 $40,790,000 -$4,715,000 -10% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $146,574,000 $35,010,000 +$908,000 +2.7% 01 Oct 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
Q3 2019 $145,666,000 $24,126,000 -$10,757,000 -31% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020 2020 Q3
Q2 2019 $156,423,000 $41,933,000 +$8,057,000 +24% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $148,366,000 $45,505,000 +$17,054,000 +60% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $131,312,000 $34,102,000 +$11,769,000 +53% 01 Oct 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
Q3 2018 $119,543,000 $34,883,000 +$13,411,000 +62% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 $106,132,000 $33,876,000 +$12,618,000 +59% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $93,514,000 $28,451,000 +$7,539,000 +36% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $85,975,000 $22,333,000 +$7,174,000 +47% 01 Oct 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
Q3 2017 $78,801,000 $21,472,000 +$3,886,000 +22% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018 2018 Q3
Q2 2017 $74,915,000 $21,258,000 +$1,998,000 +10% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $72,917,000 $20,912,000 +$809,000 +4% 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018 2018 Q1
Q4 2016 $72,108,000 $15,159,000 -$2,248,000 -13% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
Q3 2016 $74,356,000 $17,586,000 +$2,589,000 +17% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $71,767,000 $19,260,000 +$5,655,000 +42% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $66,112,000 $20,103,000 +$6,798,000 +51% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q4 2015 $59,314,000 $17,407,000 +$8,919,000 +105% 01 Oct 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
Q3 2015 $50,395,000 $14,997,000 +$6,879,000 +85% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $43,516,000 $13,605,000 +$5,897,000 +77% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q1 2015 $37,619,000 $13,305,000 +$6,236,000 +88% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q4 2014 $31,383,000 $8,488,000 +$5,387,000 +174% 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $25,996,000 $8,118,000 +$5,306,000 +189% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q2 2014 $20,690,000 $7,708,000 +$5,072,000 +192% 01 Apr 2014 30 Jun 2014 10-Q 05 Aug 2015 2015 Q2
Q1 2014 $15,618,000 $7,069,000 +$4,200,000 +146% 01 Jan 2014 31 Mar 2014 10-Q 05 May 2015 2015 Q1
Q4 2013 $11,418,000 $3,101,000 +$1,291,000 +71% 01 Oct 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
Q3 2013 $10,127,000 $2,812,000 +$778,000 +38% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2014 Q3
Q2 2013 $9,349,000 $2,636,000 +$176,000 +7.2% 01 Apr 2013 30 Jun 2013 10-Q 04 Aug 2014 2014 Q2
Q1 2013 $9,173,000 $2,869,000 +$602,000 +27% 01 Jan 2013 31 Mar 2013 10-Q 06 May 2014 2014 Q1
Q4 2012 $8,571,000 $1,810,000 -$439,000 -20% 01 Oct 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
Q3 2012 $9,010,000 $2,034,000 -$330,000 -14% 01 Jul 2012 30 Sep 2012 10-Q 05 Nov 2013 2013 Q3
Q2 2012 $9,340,000 $2,460,000 -$40,000 -1.6% 01 Apr 2012 30 Jun 2012 10-Q 06 Aug 2013 2013 Q2
Q1 2012 $9,380,000 $2,267,000 -$465,000 -17% 01 Jan 2012 31 Mar 2012 10-Q 07 May 2013 2013 Q1
Q4 2011 $9,845,000 $2,249,000 01 Oct 2011 31 Dec 2011 10-K 03 Mar 2014 2013 FY
Q3 2011 $2,364,000 -$596,000 -20% 01 Jul 2011 30 Sep 2011 10-Q 06 Nov 2012 2012 Q3
Q2 2011 $2,500,000 -$632,000 -20% 01 Apr 2011 30 Jun 2011 10-Q 06 Aug 2012 2012 Q2
Q1 2011 $2,732,000 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012 2012 Q1
Q3 2010 $2,960,000 01 Jul 2010 30 Sep 2010 10-Q 08 Nov 2011 2011 Q3
Q2 2010 $3,132,000 01 Apr 2010 30 Jun 2010 10-Q 08 Aug 2011 2011 Q2

IONIS PHARMACEUTICALS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $130,200,000 +$24,391,000 +23% 01 Jan 2024 31 Dec 2024 10-K 19 Feb 2025 2024 FY
2023 $105,809,000 +$5,545,000 +5.5% 01 Jan 2023 31 Dec 2023 10-K 19 Feb 2025 2024 FY
2022 $100,264,000 -$20,414,000 -17% 01 Jan 2022 31 Dec 2022 10-K 19 Feb 2025 2024 FY
2021 $120,678,000 -$109,439,000 -48% 01 Jan 2021 31 Dec 2021 10-K 21 Feb 2024 2023 FY
2020 $230,117,000 +$83,543,000 +57% 01 Jan 2020 31 Dec 2020 10-K 22 Feb 2023 2022 FY
2019 $146,574,000 +$15,262,000 +12% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $131,312,000 +$45,337,000 +53% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $85,975,000 +$13,867,000 +19% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $72,108,000 +$12,794,000 +22% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $59,314,000 +$27,931,000 +89% 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
2014 $31,383,000 +$19,965,000 +175% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $11,418,000 +$2,847,000 +33% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
2012 $8,571,000 -$1,274,000 -13% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
2011 $9,845,000 -$2,314,000 -19% 01 Jan 2011 31 Dec 2011 10-K 03 Mar 2014 2013 FY
2010 $12,159,000 01 Jan 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.